Literature DB >> 19393124

A tale of two parasites: the comparative epidemiology of cryptosporidiosis and giardiasis.

S J Snel1, M G Baker, V Kamalesh, N French, J Learmonth.   

Abstract

New Zealand has a higher reported incidence of cryptosporidiosis and giardiasis than most other developed countries. This study aimed to describe and compare the epidemiology of these infections in New Zealand, to better understand their impact on public health and to gain insight into their probable modes of transmission. We analysed cryptosporidiosis and giardiasis notification data for a 10-year period (1997-2006). Highest rates for both diseases were in Europeans, children aged 0-5 years, and those living in low-deprivation areas. Cryptosporidiosis distribution was consistent with mainly farm animal (zoonotic) reservoirs. There was a dose-response relationship with increasing grades of rurality, marked spring seasonality, and positive correlation with farm animal density. Giardiasis distribution was consistent with predominantly human (anthroponotic) reservoirs, with an important contribution from overseas travel. Further research should focus on methods to reduce transmission of Cryptosporidium in rural areas and on reducing anthroponotic transmission of Giardia.

Entities:  

Mesh:

Year:  2009        PMID: 19393124     DOI: 10.1017/S0950268809002465

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  25 in total

1.  Evolutionary processes in populations of Cryptosporidium inferred from gp60 sequence data.

Authors:  Juan C Garcia-R; David T S Hayman
Journal:  Parasitol Res       Date:  2017-05-13       Impact factor: 2.289

Review 2.  Giardia duodenalis: the double-edged sword of immune responses in giardiasis.

Authors:  Shahram Solaymani-Mohammadi; Steven M Singer
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

3.  Cryptosporidiosis Risk in New Zealand Children Under 5 Years Old is Greatest in Areas with High Dairy Cattle Densities.

Authors:  Aparna Lal; Timothy Dobbins; Nasser Bagheri; Michael G Baker; Nigel P French; Simon Hales
Journal:  Ecohealth       Date:  2016-10-20       Impact factor: 3.184

4.  Giardiasis in North West England: faecal specimen requesting rates by GP practice.

Authors:  N F Reeve; T R Fanshawe; K Lamden; P J Diggle; J Cheesbrough; T J Keegan
Journal:  Epidemiol Infect       Date:  2014-09-30       Impact factor: 4.434

5.  First report of Toxoplasma gondii sporulated oocysts and Giardia duodenalis in commercial green-lipped mussels (Perna canaliculus) in New Zealand.

Authors:  Alicia Coupe; Laryssa Howe; Elizabeth Burrows; Abigail Sine; Anthony Pita; Niluka Velathanthiri; Emilie Vallée; David Hayman; Karen Shapiro; Wendi D Roe
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

6.  Geographic determinants of reported human Campylobacter infections in Scotland.

Authors:  Paul R Bessell; Louise Matthews; Alison Smith-Palmer; Ovidiu Rotariu; Norval J C Strachan; Ken J Forbes; John M Cowden; Stuart W J Reid; Giles T Innocent
Journal:  BMC Public Health       Date:  2010-07-15       Impact factor: 3.295

7.  Epidemiological and clinical description of the top three reportable parasitic diseases in a Canadian community.

Authors:  A Ravel; A Nesbitt; K Pintar; A Macarthur; H-L Wang; B Marshall; F Pollari
Journal:  Epidemiol Infect       Date:  2012-05-25       Impact factor: 4.434

8.  Incidence of and risks associated with Giardia infections in herds on dairy farms in the New York City Watershed.

Authors:  Miguella P Mark-Carew; Yasin Khan; Susan E Wade; Stephanie Schaaf; Hussni O Mohammed
Journal:  Acta Vet Scand       Date:  2010-06-21       Impact factor: 1.695

9.  Inequalities in the incidence of infectious disease in the North East of England: a population-based study.

Authors:  G J Hughes; R Gorton
Journal:  Epidemiol Infect       Date:  2014-03-18       Impact factor: 4.434

10.  Heterogeneity in hotspots: spatio-temporal patterns in neglected parasitic diseases.

Authors:  A Lal; S Hales
Journal:  Epidemiol Infect       Date:  2014-05-12       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.